Contec Medical Financials
| 300869 Stock | 15.12 0.77 4.85% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 194 M | 109.1 M |
|
|
Contec | Select Account or Indicator |
Understanding current and past Contec Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Contec Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Contec Medical's assets may result in an increase in income on the income statement.
Please note, the presentation of Contec Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Contec Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Contec Medical's management manipulating its earnings.
Contec Medical Stock Summary
Contec Medical competes with Eastern Air, CITIC Metal, Hainan Mining, Ye Chiu, and Jonjee Hi. Contec Medical is entity of China. It is traded as Stock on SHE exchange.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | China Stock View All |
| Exchange | Shenzhen Stock Exchange |
| ISIN | CNE1000047F0 |
| Business Address | No112 Qinhuang West |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.contecmed.com |
| Phone | 86 33 5801 5430 |
You should never invest in Contec Medical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Contec Stock, because this is throwing your money away. Analyzing the key information contained in Contec Medical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Contec Medical Key Financial Ratios
Contec Medical's financial ratios allow both analysts and investors to convert raw data from Contec Medical's financial statements into concise, actionable information that can be used to evaluate the performance of Contec Medical over time and compare it to other companies across industries.| Revenue | 734.05 M | ||||
| Gross Profit | 330 M | ||||
| EBITDA | 136.65 M | ||||
| Net Income | 165.77 M | ||||
| Total Asset | 3.22 B |
Contec Medical Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 679.2M | 2.1B | 2.8B | 3.7B | 3.2B | 3.4B | |
| Other Current Liab | 12.6M | 115.1M | 60.9M | 76.6M | 51.7M | 60.0M | |
| Net Debt | (165.4M) | (546.1M) | 180.3M | 183.3M | 576.7M | 605.5M | |
| Retained Earnings | 166.6M | 718.1M | 936.0M | 992.2M | 1.1B | 1.1B | |
| Accounts Payable | 33.1M | 93.4M | 47.6M | 54.3M | 17.8M | 16.9M | |
| Cash | 184.3M | 814.1M | 624.0M | 1.4B | 470.5M | 422.7M | |
| Net Receivables | 63.9M | 117.3M | 115.4M | 201.2M | 47.0M | 75.7M | |
| Inventory | 128.1M | 284.4M | 418.7M | 430.2M | 463.2M | 245.8M | |
| Other Current Assets | 8.8M | 51.4M | 194.1M | 487.7M | 8.6M | 8.2M | |
| Total Liab | 96.0M | 529.0M | 969.0M | 1.8B | 1.2B | 1.2B | |
| Total Current Assets | 385.1M | 1.3B | 1.4B | 2.6B | 2.5B | 2.6B | |
| Intangible Assets | 15.2M | 13.1M | 33.6M | 57.5M | 54.7M | 57.5M | |
| Other Liab | 14.8M | 14.1M | 10.6M | 20.9M | 24.1M | 15.4M | |
| Net Tangible Assets | 568.0M | 1.6B | 1.8B | 1.9B | 2.2B | 1.1B | |
| Net Invested Capital | 602.1M | 1.8B | 2.6B | 3.5B | 3.1B | 2.0B | |
| Net Working Capital | 304.0M | 752.3M | 396.5M | 1.4B | 2.0B | 2.1B |
Contec Medical Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 85.6K | 2.4M | 2.9M | 19.1M | 45.1M | 47.4M | |
| Total Revenue | 387.2M | 1.4B | 908.7M | 712.1M | 734.0M | 609.6M | |
| Gross Profit | 182.9M | 816.2M | 446.0M | 338.1M | 404.7M | 317.7M | |
| Operating Income | 81.6M | 714.6M | 405.7M | 219.3M | 109.1M | 194.0M | |
| Ebit | 86.0M | 722.7M | 422.0M | 200.0M | 109.1M | 198.4M | |
| Research Development | 40.6M | 48.7M | 66.1M | 93.3M | 104.6M | 54.0M | |
| Ebitda | 98.1M | 736.2M | 438.2M | 219.0M | 136.7M | 214.3M | |
| Cost Of Revenue | 204.3M | 585.0M | 462.8M | 374.0M | 329.4M | 291.9M | |
| Income Before Tax | 81.9M | 715.5M | 408.0M | 219.4M | 186.1M | 208.0M | |
| Net Income | 73.8M | 613.4M | 352.4M | 196.2M | 165.8M | 181.4M | |
| Income Tax Expense | 8.1M | 102.1M | 55.6M | 23.2M | 20.4M | 26.7M | |
| Tax Provision | 8.1M | 102.1M | 55.6M | 23.2M | 20.4M | 33.6M | |
| Net Interest Income | 19.3M | 30.7M | 63.2M | 63.6M | 33.8M | 32.2M | |
| Interest Income | 20.5M | 34.6M | 67.1M | 84.3M | 81.2M | 43.1M |
Contec Medical Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Contec Medical Systems. It measures of how well Contec is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Contec Medical brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Contec had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Contec Medical has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (18.9M) | (168.0M) | (145.0M) | (17.4M) | (85.0M) | (80.8M) | |
| Change In Cash | 26.0M | 650.7M | (214.6M) | 788.8M | (922.2M) | (876.1M) | |
| Free Cash Flow | 42.8M | 509.1M | (101.7M) | 22.2M | 257.9M | 270.8M | |
| Depreciation | 12.2M | 13.4M | 16.3M | 19.1M | 27.5M | 15.9M | |
| Other Non Cash Items | (6.9M) | 6.8M | (104.2M) | (91.8M) | 195.6M | 205.4M | |
| Capital Expenditures | 7.4M | 88.7M | 106.3M | 81.4M | 30.7M | 41.0M | |
| Net Income | 73.8M | 613.4M | 352.4M | 196.2M | 165.8M | 181.4M | |
| End Period Cash Flow | 162.4M | 813.1M | 598.6M | 1.4B | 470.5M | 396.0M | |
| Investments | (24.6M) | (230M) | 50M | (50M) | (723.0M) | (686.8M) | |
| Change To Netincome | (621.7K) | 4.2M | (105.8M) | (93.3M) | (84.0M) | (79.8M) |
Contec Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Contec Medical's current stock value. Our valuation model uses many indicators to compare Contec Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Contec Medical competition to find correlations between indicators driving Contec Medical's intrinsic value. More Info.Contec Medical Systems is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Contec Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Contec Medical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Contec Medical Systems Systematic Risk
Contec Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Contec Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Contec Medical Systems correlated with the market. If Beta is less than 0 Contec Medical generally moves in the opposite direction as compared to the market. If Contec Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Contec Medical Systems is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Contec Medical is generally in the same direction as the market. If Beta > 1 Contec Medical moves generally in the same direction as, but more than the movement of the benchmark.
Contec Medical Systems Total Assets Over Time
Contec Medical Thematic Clasifications
Contec Medical Systems is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Contec Medical November 24, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Contec Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Contec Medical Systems. We use our internally-developed statistical techniques to arrive at the intrinsic value of Contec Medical Systems based on widely used predictive technical indicators. In general, we focus on analyzing Contec Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Contec Medical's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.27 | |||
| Information Ratio | 0.0388 | |||
| Maximum Drawdown | 26.16 | |||
| Value At Risk | (4.14) | |||
| Potential Upside | 3.62 |
Complementary Tools for Contec Stock analysis
When running Contec Medical's price analysis, check to measure Contec Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Contec Medical is operating at the current time. Most of Contec Medical's value examination focuses on studying past and present price action to predict the probability of Contec Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Contec Medical's price. Additionally, you may evaluate how the addition of Contec Medical to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |